surgical approach News
-
Coming Soon – The next addition to the EMPOWR Platform
EMPOWR Acetabular™ is DJO’s modern, premium, intelligently designed acetabular system featuring advanced fixation technologies, efficient instrumentation, and a feature enabling future dual mobility offering.1 This system – combined with our femoral stem options which all have 12/14 robust micro-threaded trunnions – provides surgeons a comprehensive THA solution for all ...
-
Vybion`s Huntington Drug Neutralizes Critical Disease Driver
Vybion will present data on how its drug, INT41, alters a critical event in the development of Huntington's disease at the 7th Neurodegenerative Conditions Research & Development Conference in Boston on September 9-10, 2013. INT41 is an Intrabody drug delivered by Gene Therapy that blocks gene dysregulation in Huntington's Disease by neutralizing a toxic fragment of the Huntingtin mutant ...
By Vybion
-
Carlsmed aprevo Wins Spine Technology Award
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed announced today that aprevo® has been recognized by Orthopedics This Week with the prestigious Spine Technology Award. This award was presented at a ceremony today at the North American Spine Society (NASS) meeting in Boston. The award is given annually to exemplary and innovative spine surgery products that improve spine care, as judged by a panel ...
-
Vilex Acquires DT MedTech and the Hintermann Series System Total Ankle Prostheses
Vilex, LLC, a member of the Squadron Capital family of businesses, announced today that it has successfully completed the acquisition of DT MedTech, LLC, whose product lines include the Hintermann Series System™ Total Ankle Replacement (TAR), developed by prominent surgeon, Professor Beat Hintermann. This exceptional TAR system includes the Hintermann Series H3 (H3) 3-piece, mobile-bearing ...
-
IlluminOss Medical Receives Clearance to Expand Clinical Indications in the U.S.
IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that the IlluminOss Photodynamic Bone Stabilization System has received additional clinical clearance and is now indicated by the U.S. Food and Drug Administration (FDA) for use in skeletally mature patients in the treatment of traumatic, ...
-
Preliminary Data Presented from First U.S. Clinical Trial of IlluminOss Medical`s Photodynamic Bone Stabilization System
IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that Richard Terek, M.D., presented the first preliminary data from its U.S. pivotal clinical trial at the recent Musculoskeletal Tumor Society (MSTS) Meeting in Detroit. The IlluminOss System is the world’s only system of its kind which ...
-
Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi Dilumen C2
A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue. The endolumenal ...
By Lumendi Ltd.
-
Interview with Dr. Ricardo Henriques, Master Clinical Trainer
What is the current status of new technologies in the surgical phase of dental implantology? Researchers and clinicians are increasingly aware of the factors that ensure positive treatment outcomes in implant rehabilitation of the dentition. Innovative software merged with cbCT data sets provides the means to plan the position and angulation of virtual implants. 3D printing or milling ...
By ClaroNav
-
Medtronic to Acquire Avenu Medical
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Avenu Medical, a privately held medical device company based in San Juan Capistrano, Calif. focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis. Terms of the transaction were not ...
-
IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss Bone Stabilization System
IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that it has received U.S. Food and Drug Administration (FDA) de novo clearance for the IlluminOss Bone Stabilization System for treatment of impending and actual pathological fractures of the humerus, radius and ulna from metastatic bone disease. ...
-
Silver Bullet Therapeutics Secures CE Mark Approval for Revolutionary New Antimicrobial Bone Screw System
Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it has received recommendation for CE Mark approval for the commercial sale of its antimicrobial OrthoFuzIon™ Bone Screw System in the European Union for orthopedic reduction and internal fixation procedures anywhere in the body. Over the next few months, Silver Bullet will be finalizing launch ...
-
iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries in Switzerland
The only commercially available MIGS device currently targeting the supraciliary space now available to patients and surgeons in Switzerland First implantations performed by Prof. Dr Kaweh Mansouri at Swiss Visio, Clinique de Montchoisi, Lausanne and Prof. Dr med. Jan Darius Unterlauft at Inselspital, Bern WAVRE, Belgium — 10 May 2022: iSTAR Medical, a medtech company delivering ...
-
IlluminOss Medical Completes Enrollment for U.S. Clinical Trial Using Groundbreaking Photodynamic Bone Stabilization System
IlluminOss Medical, a privately-held, commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced it has completed enrollment in its first U.S. clinical trial towards FDA approval of its IlluminOss System, the world’s first and only system of its kind which supports the treatment of fractures using patient-specific intramedullary ...
-
How to License or Sell Your Medical Device Intellectual Property
Part I – Presenting Your Idea Anywhere during the product development cycle, it may make sense to discuss your medical device with potential acquirers. Licensing implies that you will still control the company that the technology was developed under and ONLY the intellectual property is transferred to the acquirer. A license can be exclusive (1 company) or non-exclusive (you can license ...
-
A Brand New Collaboration Between Emovi and The Geneva Foundation
In partnership with The Geneva Foundation and supporting grant from the Quebec Ministry of Economy and Innovation, Emovi will launch the 24-month clinical project within US Army clinics at Fort Bragg and High Point University, North Carolina, USA Emovi, Inc., a leading medical device developer and manufacturer for orthopaedics, announced today a clinical collaboration with the US Army in ...
By Emovi
-
Palisade Bio And Newsoara Receive NMPA Clearance To Commence Phase 3 Clinical Trial In China Evaluating LB1148 To Accelerate The Return Of Bowel Function Following Abdominal Surgery
NMPA clearance expands global Phase 3 clinical development program; Company recently announced clearance from U.S. Food and Drug Administration to commence Phase 3 study Newsoara to fully fund Phase 3 program in China Under the Co-Development Agreement, commencement of Phase 3 program in China will trigger milestone payment to Palisade Bio Palisade Bio (Nasdaq: PALI), a clinical stage ...
By Palisade Bio
-
Excite Medical displays the DRX9000 at the Wave 2019
Excite Medical, the leading provider of non-surgical spinal decompression machines, announced that they will participate in the upcoming WAVE Convention and Expo held at the Oakland Marriot City Center in Oakland, CA starting on August 16th. As an exhibitor, Excite Medical will present their flagship product, the DRX9000® non-surgical spinal decompression machine in front of over 2000 ...
-
First tahoe unicompartmental knee system (TUKS) procedure
El Dorado Hills, CA, June 2022 – Shalby Advanced Technologies, (DBA Consensus Orthopedics) proudly reports its first implantation of The Tahoe Uni-compartmental Knee System (TUKS), in Plano,Texas on June 2, 2022. The surgery was performed by Dr. Richard Reitman and was a great surgical success. This surgery marks the culmination of over 6 years of research and development. The patient, a 52 ...
-
SeaSpine Announces CE Mark Certification of 7D Surgical Cranial Module and Percutaneous Spine Module for Minimally Invasive Spine Surgery
CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH™ Navigation System. This achievement expands the ...
By 7D Surgical
-
Veteran-Owned Company, in Partnership With Synaptive Medical, Awarded Medical Equipment ECAT Contract for Modus V™
Fidelis Sustainability Distribution, a veteran-owned company, has been awarded a Medical Equipment ECAT contract by the Defense Logistics Agency valued at $45,000,000 USD over 5 years. The ECAT contract is an online source (electronic catalog) for Robotic Assisted Surgery and other OR related products and acts as one of the preferred purchasing sources for the Department of Defense (DoD) and the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you